The Framingham Heart Study (FHS) is a long-standing research partnership involving Boston University. FHS uses BU research computing infrastructure, including systems housed at the MGHPCC, to store and manage large clinical, genetic, imaging, and derived datasets while providing the computational resources needed to analyze those data and uncover new insights into cardiovascular disease. As an academic partner of Boston University, the Framingham Heart Study (FHS) uses the MGHPCC to hold both core and derivative data sets while also providing the computational tools central to revealing the latent epidemiological information they hold.
The Study, which aimed to unravel the underlying causes of heart disease, started in 1948 with 5,209 participants in the town of Framingham, Massachusetts. Participants underwent physical examinations, gave blood samples for laboratory tests, and provided lifestyle and medical history information at regular intervals. Now a joint project of the National Heart, Lung, and Blood Institute) and (MGHPCC partner) Boston University, FHS has expanded over the years, both in geographical and population scope. Today it includes many grandchildren and spouses in three generations of participants, as well as two cohorts of minority participants.
Over the years, careful monitoring of the Framingham Study population has led to the identification of major cardiovascular disease risk factors, as well as valuable information on the effects of these factors such as blood pressure, blood triglyceride and cholesterol levels, age, gender, and psychosocial issues. Risk factors for other physiological conditions such as dementia have been and continue to be investigated. In addition, the relationships between physical traits and genetic patterns are being studied.
Recent discoveries from Framingham researchers highlight the study’s ongoing impact. Examples include one investigation found that individuals who maintained higher levels of physical activity during midlife and later life experienced substantially lower risks of developing dementia, reinforcing the importance of exercise as a potentially modifiable factor for brain health. Another review highlighted how Framingham research transformed modern medicine by identifying major cardiovascular risk factors, including high blood pressure, elevated cholesterol, smoking, obesity, and diabetes, findings that continue to guide prevention and treatment worldwide.
These advances matter because they provide practical, evidence-based strategies that can improve health outcomes for millions of people. Boston University Research Computing helps make this work possible by enabling researchers to analyze decades of participant records, imaging data, genetic information, and other large-scale datasets, allowing scientists to uncover patterns that would be impossible to detect through traditional methods alone.
Mid- and Late-Life Exercise May Cut Risk of Dementia BU News
10 Ways the Framingham Heart Study Has Revolutionized Healthcare BU News
